Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,439,796
-$683,094 QoQ
Shares Held
12,556
-54.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#135
of 271 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,860,153 across 147 Biotechnology names. KYMR ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
This page
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in KYMR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,439,796 | 12,556 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $2,122,890 | 27,283 | Shares | Defined | 2026-02-23 | |
| 2025-06-30 | $452,197 | 10,362 | Shares | Defined | 2025-08-12 | |
| 2024-03-31 | $206,909 | 5,147 | Shares | Defined | 2024-05-20 | |
| 2021-06-30 | $295,122 | 6,085 | Shares | Defined | 2021-09-17 | |
| 2021-03-31 | $460,801 | 11,858 | Shares | Defined | 2021-05-19 | |
| No filing history on record for this holder in this stock. | ||||||